Accelerating Structure-based Drug Design for Complex Membrane Proteins - Top-Institutions - MDSpire

Accelerating Structure-based Drug Design for Complex Membrane Proteins

Nuclera and leadXpro partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targets

  • March 9, 2026

  • 3 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    The Scripps Research Institute
    The Scripps Research Institute

    La Jolla, CA

    Key Differentiators

    • Structural Biology
    • Membrane Protein Biochemistry
    • Cryo-EM
    • AI in Drug Discovery

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Structural Biology
    • Membrane Protein Research
    • Cryo-EM
    • Computational Biology

  • #3

    Max Planck Institute of Biophysics
    Max Planck Institute of Biophysics

    Frankfurt, Hessen

    Key Differentiators

    • Biophysics
    • Membrane Protein Structural Biology
    • Cryo-EM
    • AI Applications

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Structural Biology
    • Membrane Protein Drug Targets
    • Cryo-EM
    • AI in Therapeutics

  • #5

    European Molecular Biology Laboratory (EMBL) - Hamburg Unit
    European Molecular Biology Laboratory (EMBL) - Hamburg Unit

    Hamburg, Germany

    Key Differentiators

    • Structural Biology
    • Membrane Protein Research
    • Cryo-EM
    • Computational Biology

Original Source(s)

Accelerating Structure-based Drug Design for Complex Membrane Proteins

  • March 9, 2026

Related Content

Why “Clean” Cannabis May Not Be Clean 

A multi-method study finds fungal spores, DNA, and mycotoxins persisting in irradiated cannabis 

  • February 4, 2026

  • 3 min
Maternal and Pediatric Use of Vaccines for Mpox: A Living Systematic Review and Meta-analysis of Safety and Effectiveness

GlycoRNA Comes into Focus with Mass Spectrometry Blueprint

New review maps analytical workflows to decode a surprising class of sugar-coated RNA

  • March 30, 2026

  • 2 min